Chen Y - Search Results

1

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?

Cheng X, Xu J, Chen Y, Liu Z, Sun G, Yang L, Yao J, Zeng H, Song B. Cheng X, et al. Among authors: chen y. Front Oncol. 2021 Feb 26;11:643051. doi: 10.3389/fonc.2021.643051. eCollection 2021. Front Oncol. 2021. PMID: 33718240 Free PMC article.

2

Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management.

Ge L, Chen Y, Yan C, Zhao P, Zhang P, A R, Liu J. Ge L, et al. Among authors: chen y. Front Oncol. 2019 Nov 28;9:1296. doi: 10.3389/fonc.2019.01296. eCollection 2019. Front Oncol. 2019. PMID: 31850202 Free PMC article. Review.

3

Quantitative analysis of chest CT imaging findings with the risk of ARDS in COVID-19 patients: a preliminary study.

Wang Y, Chen Y, Wei Y, Li M, Zhang Y, Zhang N, Zhao S, Zeng H, Deng W, Huang Z, Ye Z, Wan S, Song B. Wang Y, et al. Among authors: chen y. Ann Transl Med. 2020 May;8(9):594. doi: 10.21037/atm-20-3554. Ann Transl Med. 2020. PMID: 32566621 Free PMC article.

4

A Quantitative and Radiomics approach to monitoring ARDS in COVID-19 patients based on chest CT: a retrospective cohort study.

Chen Y, Wang Y, Zhang Y, Zhang N, Zhao S, Zeng H, Deng W, Huang Z, Liu S, Song B. Chen Y, et al. Int J Med Sci. 2020 Jul 6;17(12):1773-1782. doi: 10.7150/ijms.48432. eCollection 2020. Int J Med Sci. 2020. PMID: 32714080 Free PMC article.

5

Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.

Zhao J, Zhang W, Zhang J, Chen YT, Ma WJ, Liu SY, Li FY, Song B. Zhao J, et al. Cancer Manag Res. 2020 Dec 22;12:13111-13123. doi: 10.2147/CMAR.S289094. eCollection 2020. Cancer Manag Res. 2020. PMID: 33376403 Free PMC article.

6

Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Sun G, Zhang X, Liang J, Pan X, Zhu S, Liu Z, Armstrong CM, Chen J, Lin W, Liao B, Lin T, Huang R, Zhang M, Zheng L, Yin X, Nie L, Shen P, Zhao J, Zhang H, Dai J, Shen Y, Li Z, Liu J, Chen J, Liu J, Wang Z, Zhu X, Ni Y, Qin D, Yang L, Chen Y, Wei Q, Li X, Zhou Q, Huang H, Yao J, Chen N, Zeng H. Sun G, et al. Among authors: chen j, chen n, chen y. Clin Cancer Res. 2021 Mar 15;27(6):1734-1743. doi: 10.1158/1078-0432.CCR-20-3788. Epub 2021 Jan 7. Clin Cancer Res. 2021. PMID: 33414138

7

Arterial Spin Labeling MRI for Predicting Microvascular Invasion of T1 Staging Renal Clear Cell Carcinoma Preoperatively.

Zhang HM, Wen DG, Wang Y, Bao YG, Yuan Y, Chen YT, Song B. Zhang HM, et al. Among authors: chen yt. Front Oncol. 2021 May 18;11:644975. doi: 10.3389/fonc.2021.644975. eCollection 2021. Front Oncol. 2021. PMID: 34084743 Free PMC article.

8

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.

Sun G, Chen J, Liang J, Yin X, Zhang M, Yao J, He N, Armstrong CM, Zheng L, Zhang X, Zhu S, Sun X, Yang X, Zhao W, Liao B, Pan X, Nie L, Yang L, Chen Y, Zhao J, Zhang H, Dai J, Shen Y, Liu J, Huang R, Liu J, Wang Z, Ni Y, Wei Q, Li X, Zhou Q, Huang H, Liu Z, Shen P, Chen N, Zeng H. Sun G, et al. Among authors: chen j, chen n, chen y. Nat Commun. 2021 Sep 6;12(1):5262. doi: 10.1038/s41467-021-25618-z. Nat Commun. 2021. PMID: 34489456 Free PMC article.

9

Efficacy of second-line ICIs combined with TKIs among patients with metastatic renal cell carcinoma: a real-world study.

Zhang H, Chen J, Zhang X, Zhu X, Wang Z, Sun G, Liang J, Chen Y, Shen Y, Liu J, Li X, Wei Q, Liu Z, Zeng H, Shen P. Zhang H, et al. Among authors: chen j, chen y. Immunotherapy. 2022 Apr;14(5):309-320. doi: 10.2217/imt-2021-0108. Epub 2022 Feb 21. Immunotherapy. 2022. PMID: 35187953

10

Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

Ye L, Chen Y, Xu H, Wang Z, Li H, Qi J, Wang J, Yao J, Liu J, Song B. Ye L, et al. Among authors: chen y. Front Cell Dev Biol. 2022 Feb 25;10:814388. doi: 10.3389/fcell.2022.814388. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35281100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167,301 results

Search Page